Literature DB >> 30956211

Clarifying the diagnosis of post-inflammatory pulmonary fibrosis: a population-based study.

Ann Vu1, Amit Vasireddy1, Teng Moua1, Misbah Baqir1, Jay H Ryu1.   

Abstract

Entities:  

Year:  2019        PMID： 30956211     DOI： 10.1183/13993003.00103-2019

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  7 in total

1.  Works in Progress: Using Administrative Data to Estimate the Prevalence of Progressive Fibrosing Interstitial Lung Disease.

Authors:  Willis S Bowman; Timothy Dempsey
Journal:  Ann Am Thorac Soc       Date:  2022-07

2.  Incidence, Risk Factors, and Mortality of Clinical and Subclinical Rheumatoid Arthritis-Associated Interstitial Lung Disease: A Population-Based Cohort.

Authors:  Bilal F Samhouri; Robert Vassallo; Sara J Achenbach; Vanessa L Kronzer; John M Davis; Elena Myasoedova; Cynthia S Crowson
Journal:  Arthritis Care Res (Hoboken)       Date:  2022-01-07       Impact factor: 5.178

3.  In-hospital mortality trends among patients with idiopathic pulmonary fibrosis in the United States between 2013-2017: a comparison of academic and non-academic programs.

Authors:  Shehabaldin Alqalyoobi; Evans R Fernández Pérez; Justin M Oldham
Journal:  BMC Pulm Med       Date:  2020-11-07       Impact factor: 3.317

4.  Evaluation for clinical benefit of metformin in patients with idiopathic pulmonary fibrosis and type 2 diabetes mellitus: a national claims-based cohort analysis.

Authors:  Taylor T Teague; Stephanie R Payne; Bryan T Kelly; Timothy M Dempsey; Rozalina G McCoy; Lindsey R Sangaralingham; Andrew H Limper
Journal:  Respir Res       Date:  2022-04-11

5.  Relation of Pulmonary Diffusing Capacity Decline to HRCT and VQ SPECT/CT Findings at Early Follow-Up after COVID-19: A Prospective Cohort Study (The SECURe Study).

Authors:  Terese L Katzenstein; Jan Christensen; Thomas Kromann Lund; Anna Kalhauge; Frederikke Rönsholt; Daria Podlekareva; Elisabeth Arndal; Ronan M G Berg; Thora Wesenberg Helt; Anne-Mette Lebech; Jann Mortensen
Journal:  J Clin Med       Date:  2022-09-26       Impact factor: 4.964

6.  Outcomes for hospitalized patients with idiopathic pulmonary fibrosis treated with antifibrotic medications.

Authors:  Bryan T Kelly; Viengneesee Thao; Timothy M Dempsey; Lindsey R Sangaralingham; Stephanie R Payne; Taylor T Teague; Teng Moua; Nilay D Shah; Andrew H Limper
Journal:  BMC Pulm Med       Date:  2021-07-17       Impact factor: 3.317

7.  Impact of Idiopathic Pulmonary Fibrosis on Longitudinal Health-care Utilization in a Community-Based Cohort of Patients.

Authors:  Erica Farrand; Carlos Iribarren; Eric Vittinghoff; Tory Levine-Hall; Brett Ley; George Minowada; Harold R Collard
Journal:  Chest       Date:  2020-07-24       Impact factor: 9.410
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.